Genetic Amplification Reveals How Acinetobacter baumannii Adapts to Human Host Environments

A recent study published in mLife has uncovered a novel mechanism by which the nosocomial pathogen Acinetobacter baumannii survives and thrives within human hosts. Researchers identified that the insertion sequence ISAba1 facilitates the amplification of the crp-osmC gene cluster, forming a composite transposon known as Tn7691. This genetic alteration is strongly linked to the globally prevalent ST2 lineage, highlighting its critical role in the pathogen's clinical success and evolutionary persistence.

Experimental analysis demonstrates that increasing the copy number of the crp-osmC cluster significantly improves bacterial growth, nutrient acquisition, and survival in serum and mouse infection models. By enhancing metabolic flexibility, the bacteria can better navigate nutrient-limited host environments. These findings provide a deeper understanding of how genomic plasticity allows this dangerous pathogen to adapt beyond traditional antimicrobial resistance mechanisms.

Interestingly, the study reveals an evolutionary trade-off: while amplification boosts host-associated fitness, it simultaneously reduces biofilm formation and increases susceptibility to certain antibiotics. This discovery challenges the conventional view that insertion sequences only drive drug resistance, offering new perspectives on the complex adaptive evolution of A. baumannii and suggesting potential vulnerabilities that could be targeted in future clinical interventions.